Dr. Kenneth Rothstein, MD

NPI: 1790753317
Total Payments
$132,123
2024 Payments
$142.30
Companies
13
Transactions
178
Medicare Patients
1,306
Medicare Billing
$191,938

Payment Breakdown by Category

Other$75,530 (57.2%)
Consulting$37,560 (28.4%)
Travel$14,062 (10.6%)
Food & Beverage$4,963 (3.8%)
Education$7.93 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $65,880 24 49.9%
Consulting Fee $37,560 10 28.4%
Travel and Lodging $14,062 51 10.6%
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $5,200 2 3.9%
Food and Beverage $4,963 88 3.8%
Honoraria $4,450 2 3.4%
Education $7.93 1 0.0%

Top Paying Companies

Company Total Records Latest Year
Gilead Sciences, Inc. $46,514 63 $0 (2022)
AbbVie Inc. $41,000 69 $0 (2020)
Alexion Pharmaceuticals, Inc. $17,218 11 $0 (2023)
Bayer HealthCare Pharmaceuticals Inc. $10,392 10 $0 (2018)
Intercept Pharmaceuticals, Inc. $6,808 6 $0 (2019)
Merck Sharp & Dohme Corporation $6,764 8 $0 (2017)
ORPHALAN INC $3,185 3 $0 (2024)
Ipsen Biopharmaceuticals, Inc $129.15 1 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $34.21 2 $0 (2022)
Janssen Biotech, Inc. $28.05 2 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $142.30 2 Ipsen Biopharmaceuticals, Inc ($129.15)
2023 $6,072 3 ORPHALAN INC ($3,172)
2022 $12,136 12 Alexion Pharmaceuticals, Inc. ($11,998)
2021 $2,320 1 Alexion Pharmaceuticals, Inc. ($2,320)
2020 $1,839 4 AbbVie Inc. ($1,800)
2019 $5,529 17 AbbVie, Inc. ($5,515)
2018 $11,624 23 AbbVie, Inc. ($6,001)
2017 $92,461 116 Gilead Sciences Inc ($46,160)

All Payment Transactions

178 individual payment records from CMS Open Payments — Page 1 of 8

Date Company Product Nature Form Amount Type
10/08/2024 ORPHALAN INC CUVRIOR (Drug) Food and Beverage In-kind items and services $13.15 General
Category: Hepatology
08/14/2024 Ipsen Biopharmaceuticals, Inc IQIRVO (Drug) Food and Beverage In-kind items and services $129.15 General
Category: Rare Disease
11/13/2023 ORPHALAN INC CUVRIOR (Drug) Food and Beverage In-kind items and services $172.10 General
Category: Hepatology
11/10/2023 ORPHALAN INC CUVRIOR (Drug) Honoraria Cash or cash equivalent $3,000.00 General
Category: Hepatology
04/13/2023 Alexion Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $2,900.00 General
11/05/2022 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $54.56 General
11/04/2022 Gilead Sciences, Inc. Food and Beverage In-kind items and services $107.60 General
09/08/2022 Janssen Biotech, Inc. REMICADE (Biological), SIMPONI, SIMPONI ARIA Food and Beverage In-kind items and services $15.93 General
Category: Immunology
08/18/2022 Alexion Pharmaceuticals, Inc. Travel and Lodging Cash or cash equivalent $235.17 General
08/18/2022 Alexion Pharmaceuticals, Inc. Food and Beverage Cash or cash equivalent $19.64 General
08/16/2022 Alexion Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $10,440.00 General
07/21/2022 Alexion Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $394.19 General
07/21/2022 Alexion Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $302.90 General
07/21/2022 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $274.83 General
07/21/2022 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $151.76 General
07/21/2022 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $124.50 General
06/14/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.80 General
Category: Gastroenterology
11/30/2021 Alexion Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $2,320.00 General
08/03/2020 Gilead Sciences, Inc. Vemlidy (Drug) Education In-kind items and services $7.93 General
Category: HBV
07/22/2020 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $19.41 General
Category: GASTROENTEROLOGY
05/21/2020 AbbVie Inc. MAVYRET (Drug) Consulting Fee Cash or cash equivalent $1,800.00 General
Category: VIROLOGY
01/17/2020 Janssen Biotech, Inc. STELARA (Biological), STELARA Food and Beverage In-kind items and services $12.12 General
Category: Immunology
11/10/2019 AbbVie, Inc. Mavyret (Drug) Food and Beverage In-kind items and services $41.87 General
Category: Virology
11/06/2019 Intercept Pharmaceuticals, Inc. OCALIVA (Drug) Food and Beverage In-kind items and services $13.22 General
Category: HEPATOLOGY GASTROENTEROLOGY
06/05/2019 AbbVie, Inc. Mavyret (Drug) Consulting Fee Cash or cash equivalent $4,200.00 General
Category: Virology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 330 425 $137,355 $47,309
2022 9 380 519 $131,702 $56,370
2021 6 274 367 $115,638 $45,205
2020 10 322 430 $130,662 $43,054
Total Patients
1,306
Total Services
1,741
Medicare Billing
$191,938
Procedure Codes
43

All Medicare Procedures & Services

43 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 82 106 $42,972 $15,253 35.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 78 94 $28,760 $9,841 34.2%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 23 23 $13,443 $4,323 32.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 36 38 $9,928 $4,322 43.5%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 26 65 $13,386 $4,204 31.4%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 13 26 $7,435 $2,564 34.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 14 14 $6,692 $1,963 29.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 23 23 $3,716 $1,779 47.9%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 16 16 $6,368 $1,731 27.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 19 20 $4,655 $1,331 28.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 76 96 $34,000 $14,518 42.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 83 99 $27,165 $10,545 38.8%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 44 113 $21,018 $9,640 45.9%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 25 25 $12,225 $4,581 37.5%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 23 24 $7,800 $3,965 50.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 25 29 $6,380 $3,540 55.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 28 31 $4,340 $2,552 58.8%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 20 43 $6,063 $2,530 41.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 14 14 $5,570 $1,810 32.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 15 15 $3,410 $994.91 29.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 14 17 $1,716 $911.46 53.1%
99238 Hospital discharge day management, 30 minutes or less Facility 2022 13 13 $2,015 $781.90 38.8%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 83 117 $40,655 $16,522 40.6%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 37 37 $17,835 $6,968 39.1%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 49 51 $11,220 $6,180 55.1%

About Dr. Kenneth Rothstein, MD

Dr. Kenneth Rothstein, MD is a Transplant Hepatology healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790753317.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Rothstein, MD has received a total of $132,123 in payments from pharmaceutical and medical device companies, with $142.30 received in 2024. These payments were reported across 178 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($65,880).

As a Medicare-enrolled provider, Rothstein has provided services to 1,306 Medicare beneficiaries, totaling 1,741 services with total Medicare billing of $191,938. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.

Practice Information

  • Specialty Transplant Hepatology
  • Other Specialties Gastroenterology, Internal Medicine
  • Location Philadelphia, PA
  • Active Since 03/09/2006
  • Last Updated 10/04/2019
  • Taxonomy Code 207RT0003X
  • Entity Type Individual
  • NPI Number 1790753317

Products in Payments

  • Mavyret (Drug) $30,750
  • Epclusa (Drug) $24,021
  • Viekira (Drug) $8,450
  • Vemlidy (Drug) $6,847
  • OCA (Drug) $6,794
  • ZEPATIER (Drug) $6,764
  • Nexavar (Drug) $5,365
  • Stivarga (Drug) $5,027
  • Harvoni (Drug) $5,000
  • Vosevi (Drug) $4,664
  • CUVRIOR (Drug) $3,185
  • MAVYRET (Drug) $1,800
  • IQIRVO (Drug) $129.15
  • XIFAXAN (Drug) $34.21
  • TruClear (Device) $19.70
  • Amitiza (Drug) $16.88
  • REMICADE (Biological) $15.93
  • DARAPRIM (Drug) $14.82
  • OCALIVA (Drug) $13.22
  • STELARA (Biological) $12.12

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Transplant Hepatology Doctors in Philadelphia